The Role of Continuing Medical Education in Increasing Enrollment in Prescription Drug Monitoring Programs

John Finnell, Robert K. Twillman, Stephanie A. Breslan, Jan Schultz, Lyerka Miller

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose Opioid diversion, misuse, and abuse are rapidly growing problems in the United States; >60% of all drug overdose deaths involve an opioid. At least 49 states now have fully operational prescription drug monitoring programs (PDMPs) to support legitimate medical use of controlled substances; however, there is considerable underutilization of such programs. Methods To increase awareness of PDMPs and their use, a continuing medical education program including 2 webcasts and a series of newsletters was offered to health care providers. Findings Four hundred and sixty-five clinicians participated in 1 of 2 webcasts. Of those, 207 clinicians responded to a pre-survey and 64 responded to a post-survey. Slightly more than half of clinicians were registered for their state's PDMP program before the educational intervention, and although significantly more clinicians reported increased likelihood to access their state PDMP after participation, the number that actually registered only trended toward a statistically significant increase to 74% after the education (P = 0.06). Immediate post-activity evaluation also indicated that the education significantly improved clinician knowledge of the characteristics of addiction, findings in a PDMP that would suggest diversion or abuse, and strategies to complement the use of a PDMP (P < 0.001). Implications Continuing medical education is effective for improving clinician knowledge and confidence related to opioid misuse, abuse, and diversion and effective use of a PDMP; however, the education did not result in a significant increase in enrollment in state PDMPs.

Original languageEnglish (US)
Pages (from-to)1896-1902.e2
JournalClinical Therapeutics
Volume39
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Continuing Medical Education
Prescription Drugs
Drug Monitoring
Webcasts
Opioid Analgesics
Education
Controlled Substances
Drug Overdose
Health Personnel

Keywords

  • addiction
  • continuing medical education
  • dependence
  • diversion
  • opioids
  • prescription drug monitoring programs

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

The Role of Continuing Medical Education in Increasing Enrollment in Prescription Drug Monitoring Programs. / Finnell, John; Twillman, Robert K.; Breslan, Stephanie A.; Schultz, Jan; Miller, Lyerka.

In: Clinical Therapeutics, Vol. 39, No. 9, 01.09.2017, p. 1896-1902.e2.

Research output: Contribution to journalArticle

Finnell, John ; Twillman, Robert K. ; Breslan, Stephanie A. ; Schultz, Jan ; Miller, Lyerka. / The Role of Continuing Medical Education in Increasing Enrollment in Prescription Drug Monitoring Programs. In: Clinical Therapeutics. 2017 ; Vol. 39, No. 9. pp. 1896-1902.e2.
@article{8f6729963cf34ae2a5f353b7a5bf8d40,
title = "The Role of Continuing Medical Education in Increasing Enrollment in Prescription Drug Monitoring Programs",
abstract = "Purpose Opioid diversion, misuse, and abuse are rapidly growing problems in the United States; >60{\%} of all drug overdose deaths involve an opioid. At least 49 states now have fully operational prescription drug monitoring programs (PDMPs) to support legitimate medical use of controlled substances; however, there is considerable underutilization of such programs. Methods To increase awareness of PDMPs and their use, a continuing medical education program including 2 webcasts and a series of newsletters was offered to health care providers. Findings Four hundred and sixty-five clinicians participated in 1 of 2 webcasts. Of those, 207 clinicians responded to a pre-survey and 64 responded to a post-survey. Slightly more than half of clinicians were registered for their state's PDMP program before the educational intervention, and although significantly more clinicians reported increased likelihood to access their state PDMP after participation, the number that actually registered only trended toward a statistically significant increase to 74{\%} after the education (P = 0.06). Immediate post-activity evaluation also indicated that the education significantly improved clinician knowledge of the characteristics of addiction, findings in a PDMP that would suggest diversion or abuse, and strategies to complement the use of a PDMP (P < 0.001). Implications Continuing medical education is effective for improving clinician knowledge and confidence related to opioid misuse, abuse, and diversion and effective use of a PDMP; however, the education did not result in a significant increase in enrollment in state PDMPs.",
keywords = "addiction, continuing medical education, dependence, diversion, opioids, prescription drug monitoring programs",
author = "John Finnell and Twillman, {Robert K.} and Breslan, {Stephanie A.} and Jan Schultz and Lyerka Miller",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.clinthera.2017.07.040",
language = "English (US)",
volume = "39",
pages = "1896--1902.e2",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "9",

}

TY - JOUR

T1 - The Role of Continuing Medical Education in Increasing Enrollment in Prescription Drug Monitoring Programs

AU - Finnell, John

AU - Twillman, Robert K.

AU - Breslan, Stephanie A.

AU - Schultz, Jan

AU - Miller, Lyerka

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Purpose Opioid diversion, misuse, and abuse are rapidly growing problems in the United States; >60% of all drug overdose deaths involve an opioid. At least 49 states now have fully operational prescription drug monitoring programs (PDMPs) to support legitimate medical use of controlled substances; however, there is considerable underutilization of such programs. Methods To increase awareness of PDMPs and their use, a continuing medical education program including 2 webcasts and a series of newsletters was offered to health care providers. Findings Four hundred and sixty-five clinicians participated in 1 of 2 webcasts. Of those, 207 clinicians responded to a pre-survey and 64 responded to a post-survey. Slightly more than half of clinicians were registered for their state's PDMP program before the educational intervention, and although significantly more clinicians reported increased likelihood to access their state PDMP after participation, the number that actually registered only trended toward a statistically significant increase to 74% after the education (P = 0.06). Immediate post-activity evaluation also indicated that the education significantly improved clinician knowledge of the characteristics of addiction, findings in a PDMP that would suggest diversion or abuse, and strategies to complement the use of a PDMP (P < 0.001). Implications Continuing medical education is effective for improving clinician knowledge and confidence related to opioid misuse, abuse, and diversion and effective use of a PDMP; however, the education did not result in a significant increase in enrollment in state PDMPs.

AB - Purpose Opioid diversion, misuse, and abuse are rapidly growing problems in the United States; >60% of all drug overdose deaths involve an opioid. At least 49 states now have fully operational prescription drug monitoring programs (PDMPs) to support legitimate medical use of controlled substances; however, there is considerable underutilization of such programs. Methods To increase awareness of PDMPs and their use, a continuing medical education program including 2 webcasts and a series of newsletters was offered to health care providers. Findings Four hundred and sixty-five clinicians participated in 1 of 2 webcasts. Of those, 207 clinicians responded to a pre-survey and 64 responded to a post-survey. Slightly more than half of clinicians were registered for their state's PDMP program before the educational intervention, and although significantly more clinicians reported increased likelihood to access their state PDMP after participation, the number that actually registered only trended toward a statistically significant increase to 74% after the education (P = 0.06). Immediate post-activity evaluation also indicated that the education significantly improved clinician knowledge of the characteristics of addiction, findings in a PDMP that would suggest diversion or abuse, and strategies to complement the use of a PDMP (P < 0.001). Implications Continuing medical education is effective for improving clinician knowledge and confidence related to opioid misuse, abuse, and diversion and effective use of a PDMP; however, the education did not result in a significant increase in enrollment in state PDMPs.

KW - addiction

KW - continuing medical education

KW - dependence

KW - diversion

KW - opioids

KW - prescription drug monitoring programs

UR - http://www.scopus.com/inward/record.url?scp=85028516937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028516937&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2017.07.040

DO - 10.1016/j.clinthera.2017.07.040

M3 - Article

VL - 39

SP - 1896-1902.e2

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 9

ER -